Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study
Seizures
About this trial
This is an interventional treatment trial for Seizures focused on measuring seizure prophylaxis, enteral nutrition
Eligibility Criteria
Inclusion Criteria: On Dilantin for seizure prophylaxis (dose determined by primary caregiver) with therapeutic Dilantin levels Receiving enteral nutrition by the interrupted method at goal feeding rate Age >18 Feeding tube in proper position, no restriction as to type of feeding tube (nasogastric, nasoduodenal, gastrostomy, jejunostomy), but both Dilantin and enteral feeding must be given through the same tube Exclusion Criteria: History of seizures Albumin infusions necessary during study period Anticipation that feedings will need to be held for more than 4 hours at a time Patients that do not maintain stable Dilantin levels (< 25% variability) with the interrupted method of feeding Inability to obtain consent from patient or spokesperson